Related Experiment Video
Updated: Oct 20, 2025

Surgical Techniques for Catheter Placement and 5/6 Nephrectomy in Murine Models of Peritoneal Dialysis
Published on: July 19, 2018
Hemodiafiltration Is Associated With Reduced Inflammation and Increased Bone Formation Compared With Conventional
Dagmar-Christiane Fischer1, Colette Smith2, Francesca De Zan3
1Department of Pediatrics, Rostock University Medical Centre, Rostock, Germany.
Insights
Children on hemodiafiltration (HDF) show reduced inflammation and improved bone formation markers compared to conventional hemodialysis (HD). This suggests HDF may offer benefits for bone health in pediatric patients undergoing dialysis.
Area of Science:
- Pediatric Nephrology
- Bone Metabolism
- Renal Replacement Therapy
Background:
- Patients on dialysis face significant bone disease burden, including fractures.
- Chronic kidney disease (CKD) impacts bone health through various mechanisms.
- Understanding bone comorbidities in pediatric dialysis patients is crucial.
Purpose of the Study:
- To determine the prevalence and risk factors for CKD-related bone disease in children on hemodiafiltration (HDF) versus conventional hemodialysis (HD).
- To compare bone turnover markers, inflammatory markers, FGF-23, and klotho levels between HDF and HD cohorts.
Main Methods:
- Post hoc analysis of the prospective cohort study HDF, Hearts and Heights (3H).
- Included 103 children (61 HD, 42 HDF) with 12-month follow-up.
- Measured biomarkers of bone formation/resorption, inflammation, FGF-23, and klotho.
Main Results:
- HDF cohort showed lower inflammatory markers (IL-6, TNF-α, hs-CRP) at baseline and 12 months.
- The bone-specific alkaline phosphatase/tartrate-resistant acid phosphatase 5b ratio increased in HDF but not HD after 12 months.
- The FGF-23/klotho ratio was significantly higher in the HD group compared to HDF after 12 months.
Conclusions:
- Children on HDF exhibit an attenuated inflammatory profile and increased bone formation compared to HD.
- HDF is associated with lower FGF-23/klotho ratios, potentially indicating better bone health.
- Further long-term studies are needed to link these biomarker improvements to fracture risk and cardiovascular outcomes.
Background:
Patients on dialysis have a high burden of bone-related comorbidities, including fractures. We report a post hoc analysis of the prospective cohort study HDF, Hearts and Heights (3H) to determine the prevalence and risk factors for chronic kidney disease-related bone disease in children on hemodiafiltration (HDF) and conventional hemodialysis (HD).
Methods:
The baseline cross-sectional analysis included 144 children, of which 103 (61 HD, 42 HDF) completed 12-month follow-up. Circulating biomarkers of bone formation and resorption, inflammatory markers, fibroblast growth factor-23, and klotho were measured.
Results:
Inflammatory markers interleukin-6, tumor necrosis factor-α, and high-sensitivity C-reactive protein were lower in HDF than in HD cohorts at baseline and at 12 months (P < .001). Concentrations of bone formation (bone-specific alkaline phosphatase) and resorption (tartrate-resistant acid phosphatase 5b) markers were comparable between cohorts at baseline, but after 12-months the bone-specific alkaline phosphatase/tartrate-resistant acid phosphatase 5b ratio increased in HDF (P = .004) and was unchanged in HD (P = .44). On adjusted analysis, the bone-specific alkaline phosphatase/tartrate-resistant acid phosphatase 5b ratio was 2.66-fold lower (95% confidence interval, -3.91 to -1.41; P < .0001) in HD compared with HDF. Fibroblast growth factor-23 was comparable between groups at baseline (P = .52) but increased in HD (P < .0001) and remained unchanged in HDF (P = .34) at 12 months. Klotho levels were similar between groups and unchanged during follow-up. The fibroblast growth factor-23/klotho ratio was 3.86-fold higher (95% confidence interval, 2.15-6.93; P < .0001) after 12 months of HD compared with HDF.
Conclusion:
Children on HDF have an attenuated inflammatory profile, increased bone formation, and lower fibroblast growth factor-23/klotho ratios compared with those on HD. Long-term studies are required to determine the effects of an improved bone biomarker profile on fracture risk and cardiovascular health.
More Related Videos
Related Concept Videos
Hemodialysis I: Introduction
Hemodialysis II: Procedure and Complications
Extracorporeal Removal of Drugs: Hemoperfusion and Hemofiltration
Acute Kidney Injury V: Interprofessional Care
Dialysis
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
Hemodialysis III: Nursing Management

